Desonide
Back to searchMolecule Structure
Scientific Name
Desonide
Description of the Drug
Desonide is a topical corticosteroid used for the symptomatic treatment of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01260
http://www.drugbank.ca/drugs/DB01260
Brand Name(s)
Desonate, Desonide, Desowen, Tridesilon, Verdeso
Company Owner(s)
Cadila Healthcare Ltd, Padagis Us Llc, Cintex Services Llc, Bayer Pharmaceuticals Corp, Akorn Operating Co Llc, Aleor Dermaceuticals Ltd, Fougera Pharmaceuticals Inc, Pai Holdings Llc Dba Pharmaceutical Associates Inc, Encube Ethicals Pvt Ltd, Taro Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glucocorticoid receptor | SINGLE PROTEIN | AGONIST | CHEMBL2034 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3631 | |||
| PharmGKB | PA164776996 | |||
| Human Metabolome Database | HMDB0015389 | |||
| DrugBank | DB01260 | |||
| PubChem: Thomson Pharma | 14855707 | |||
| PubChem | 5311066 | |||
| Nikkaji | J6.927B | |||
| EPA CompTox Dashboard | DTXSID7046756 | |||
| DrugCentral | 3135 | |||
| ChemicalBook | CB2783466 | |||
| Guide to Pharmacology | 7066 | |||
| rxnorm | DESOWEN | DESONIDE | VERDESO | DESONATE |
| ChEBI | 204734 | |||
| ZINC | ZINC000004212851 |
